REYON Pharmaceutical Co., Ltd.

KSE 102460.KS

REYON Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2023: USD 30.66 M

REYON Pharmaceutical Co., Ltd. Receivables is USD 30.66 M for the year ending December 31, 2023, a -7.16% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

REYON Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2022 was USD 33.03 M, a -3.40% change year over year.
REYON Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2021 was USD 34.19 M, a -6.76% change year over year.
REYON Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2020 was USD 36.67 M, a -7.02% change year over year.
REYON Pharmaceutical Co., Ltd. Receivables for the year ending December 31, 2019 was USD 39.44 M, a -9.81% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

KSE: 102460.KS

REYON Pharmaceutical Co., Ltd.

CEO	Ms. Soon-Ock Jung
IPO Date	June 10, 2010
Location	South Korea
Headquarters	416 Yeongdong-daero
Employees	466
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Pet Food Soft Drinks & Sodas

Description

REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years